Revotek Deploys Its Bioink Technology to Research Institutes | News
CHENGDU, China , April 29, 2021 / PRNewswire / - Recently, Revotek Co., Ltd. ("Revotek"), a vertically integrated biotech company specializing in 3D bioprinting, and the West China Hospital of Sichuan University, a leading research hospital in China have reached an agreement in which the latter are to introduce cell encapsulation technology from Revotek or Biosynsphere for use in their basic and translational research in stem cell regenerative medicine. On April 22 The instrument (biosynspherer) and its first batch of reagents and consumables were shipped to the laboratory of the West China Hospital of Sichuan University. Revotek's 3D blood vessel bioprinter is expected to be delivered to the hospital laboratory in the third quarter of 2021. In the cooperation, Revotek offers training on biosynspheres, biosynsphere preparation as well